Eligard Related Clinical Trials
Efficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer [Active, not recruiting]
Evaluate Recovery of Testosterone for Patients Using Eligard [Completed]
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty [Completed]
Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty [Completed]
A Study of Leuprolide to Treat Prostate Cancer [Completed]
Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer [Active, not recruiting]
Observational, Non-interventional, Non Comparative Real Life Data Collection of Depo-Eligard� 7.5 mg, 22.5 mg and 45 mg in Male Prostate Cancer Patients [Completed]
A Study in Patients With Metastatic Prostate Cancer to Assess How the Drug Eligard®, Affects Certain Markers in Blood and Urine, Which Are Indicators for the Disease [Recruiting]
A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD [Completed]
Melanoma Vaccine With Peptides and Leuprolide [Completed]
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy [Completed]
An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation [Active, not recruiting]
Pilot Study of Lupron to Improve Immune Function After Allogeneic Bone Marrow Transplantation [Recruiting]
Leuprorelin Acetate SR 11.25 mg for Injection Specified Drug-use Survey "Long-term Use Survey on Premenopausal Breast Cancer Patients (96 Weeks)" [Completed]
Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK) [Recruiting]
Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg) [Active, not recruiting]
A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy [Completed]
Oral Microdose Lupron Versus Luteal Estradiol Trial in Poor Responder In Vitro Fertilization (IVF) Patients [Withdrawn]
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma [Recruiting]
Leuprorelin Acetate SR 11.25 mg Injection Kit Specified Drug-use Survey: "QOL Survey in Premenopausal Breast Cancer Patients" [Completed]
Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) [Active, not recruiting]
Study of Lupron Depot In The Treatment of Central Precocious Puberty [Completed]
Leuprolide Acetate or Goserelin Acetate With or Without Vismodegib Followed by Surgery in Treating Patients With Locally Advanced Prostate Cancer [Active, not recruiting]
Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)" [Completed]
Retrospective, Non-interventional Study of Depo-Eligard®. [Completed]
Lucrin� Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS) [Completed]
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate Cancer [Completed]
Initiation of Androgen Deprivation Therapy for Prostate Cancer Using Degarelix Followed by Leuprolide [Completed]
GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients [Completed]
Endometrial Markers and Response of Endometriosis Patients to Prolonged GnRH Agonist Prior to IVF [Completed]
A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA) [Terminated]
Extended Endocrine Therapy for Premenopausal Women With Breast Cancer [Active, not recruiting]
Palifermin With Leuprolide Acetate for the Promotion of Immune Recovery Following Total Body Irradiation Based T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation [Recruiting]
Eligard Observational Registry for Patients With Prostate Cancer [Active, not recruiting]
Effect of Short Term Ovarian Suppression on Androgen Overproduction in Overweight Girls With Androgen Excess [Not yet recruiting]
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Study [Active, not recruiting]
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone Acetate in Male Participants With Prostate Cancer [Completed]
Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate [Recruiting]
A Long-term Extension Study Evaluating a One-Month Dosing Regimen of Degarelix in Prostate Cancer Requiring Androgen Ablation Therapy [Completed]
Lupron Sex Offender Therapy [Active, not recruiting]
GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases [Recruiting]
A Phase 3 Comparative Study of TAP-144-SR(6M) in Postoperative and Hormone Therapy-na�ve Patients With Premenopausal Breast Cancer [Completed]
Preservation of Ovarian Function After Hematopoietic Cell Transplant [Active, not recruiting]
Benefit Evaluation of Adjuvant Hormonal Treatment for 24 Months After Radical Prostatectomy in High Risk of Recurrence Patients. [Active, not recruiting]
Pharmacodynamics of Lorelin Depot (Leuprorelin Acetate - Bergamo) Compared to Lupron Depot � (Leuprorelin Acetate - Abbot) [Completed]
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer [Completed]
Leuprolide Acetate or Goserelin Acetate Compared With Observation in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy [Terminated]
Abiraterone Acetate, Prednisone, and Leuprolide Acetate or Goserelin Before and During Radiation Therapy in Treating Patients With Localized or Locally Advanced Prostate Cancer [Active, not recruiting]
Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients [Terminated]
The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer [Completed]
Ipilimumab + Androgen Deprivation Therapy in Prostate Cancer [Active, not recruiting]
Levonorgestrel-releasing Intrauterine System in Patients With Endometriosis [Completed]
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer [Completed]
Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer [Active, not recruiting]
Safety and Efficacy Study of Leuprolide Acetate for Injectable Suspension 22.5 MG in the Treatment of Prostate Cancer [Completed]
Pharmacokinetic Study of Leuprolide Acetate Injectable Suspension in the Treatment of Central Precocious Puberty [Recruiting]
Neoadjuvant Ipilimumab in Prostate Cancer [Active, not recruiting]
A Study to Evaluate the Ability of Lupron Depot to Enhance Immune Function Following Bone Marrow Transplantation [Terminated]
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer [Completed]
Leuprolide in Treating Adults With Hypogonadotropism [Completed]
Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer [Active, not recruiting]
Pharmacokinetics, Safety and Efficacy Study of Proellex in Pre-menopausal Women With Symptomatic Uterine Fibroids [Terminated]
Leuprolide in Determining the Cause of Gonadotropin Deficiency [Completed]
ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation [Completed]
Influence of Male Hormones on Regional Fat Metabolism [Completed]
Regulation of Cortisol Metabolism and Fat Patterning [Completed]
Down-regulated Hormonally Controlled Cycles for Vitrification-warmed Blastocyst Transfers [Active, not recruiting]
Finite Androgen Ablation vs. Finite Androgen Ablation in Combination With Abiraterone Acetate and Prednisone [Recruiting]
Docetaxel, Androgen Ablation Therapy, and External-Beam Radiation Therapy in Treating Patients With High-Risk Localized Prostate Cancer [Completed]
Understanding Experimentally Induced Hot Flushes [Active, not recruiting]
Follicle-Stimulating Hormone (FSH) and the Onset of Puberty [Suspended]
The Effect of GnRH Agonist Administered in the Luteal Phase on ART Cycle Outcomes [Not yet recruiting]
Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (ALADDIN) VP 104 Study [Completed]
Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer [Completed]
Impact of Hot Flashes on Sleep and Mood Disturbance [Active, not recruiting]
Maximal Stimulation and Delayed Fertilization for Diminished Ovarian Reserve: a Randomized Pilot Study [Completed]
Effect of GTx-758 on Total and Free Testosterone Levels in Men With Prostate Cancer [Terminated]
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea [Terminated]
Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer [Recruiting]
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer [Completed]
A Study to Assess the Effectiveness and Safety of Different Doses of ASP1707 Compared to Placebo for Endometriosis Associated Pelvic Pain [Completed]
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer [Completed]
The Clinical Trial to Evaluate the Efficacy and Safety of Luphere Depot Inj. 3.75mg(Leuprolide Acetate 3.75mg) in Patients With Precocious Puberty [Completed]
External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer [Terminated]
Relationship Between the Menstrual Cycle and Heart Disease in Women [Completed]
Efficacy and Safety of TAK-385 in the Treatment of Endometriosis [Completed]
A Long-term Extension Study of TAK-385 in the Treatment of Endometriosis [Completed]
Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer [Terminated]
Observational Program to Assess Routine Use of Add-back Therapy in Patients With Endometriosis in Russian Federation, Planned for 6-month Course of Lucrin Depot® (Leuprorelin) [Completed]
Effects of Varied Estrogen Doses on Endometrial Receptivity [Recruiting]
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases [Completed]
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic T2-T3N0 Prostate Cancer [Active, not recruiting]
Enzalutamide and Hormone Therapy Before, During, and After Radiation for High Risk Localized Prostate Cancer [Recruiting]
S0032, Combination Chemotherapy Plus Hormone Therapy in Treating Patients With Metastatic Prostate Cancer [Completed]
|
